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Percutaneous aortic balloon valvuloplasty usually results in
only a modest improvement in valve hemodynamics (1,2)
with a high short-term restenosis rate (3). Nonetheless,
patients who undergo this procedure usually have an initial
improvement in symptoms and many demonstrate sustained
symptomatic benefit at follow-up despite documented valve
restenosis (2,3). There has consistently been a lack of
relation between recurrent symptoms and the conventional
variables used to evaluate aortic stenosis in patients after
aortic valvuloplasty. Such variables include measurements
of outflow obstruction (valve gradient and valve area) as well
as systolic ejection indexes (cardiac output and ejection
fraction). It has been suggested that there is a "critical"
level of obstruction that. when exceeded, produces symp-
toms (3,4). Perhaps the commonly used hydraulic and con-
tinuity methods to determine valve area may not be able to
determine this level, which may vary from patient to patient.
However. other reasons for this observed symptomatic
improvement may be present that are not measured in daily
clinical practice.
Left ventricular diastolic function in aortic stenosis. In the
presence of long-term pressure overload, systolic function is
usually well preserved. The increase in systolic wall stress
produced by the stenotic aortic valve leads to parallel
replication of sarcomeres and concentric hypertrophy,
which tends to normalize wall tension (5). However, there
are adverse pathophysiologic effects of this hypertrophy on
diastolic filling of the ventricle that result in increased
diastolic pressures as well as diffuse subendocardial ische-
mia (6-8). Both of these factors contribute to symptoms in
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patients with aortic stenosis, that is, symptoms due to
diastolic abnormalities of the left ventricle.
The mechanism ofleft ventricular diastolic dysfunction in
pressure overload hypertrophy is multifactorial and many
aspects remain controversial. Excess afterload, myocardial
ischemia and intrinsic abnormalities of the hypertrophied
myocardium all play a role in producing these diastolic
abnormalities. Impairment of left ventricular relaxation is
often present in patients with aortic stenosis. This has been
attributed to afterload mismatch that slows relaxation in
both the isolated cardiac muscle preparation and the intact
canine model (9, 10). There is also evidence that other factors
(extent of hypertrophy, abnormalities of calcium regulation
or ischemia) account for abnormalities of relaxation (\ 1.12),
Chamber stiffness is increased, producing higher diastolic
pressures during filling. This increase in chamber stiffness
may be due to an increase in muscle mass in some patients;
in others, enhanced myocardial elastic stiffness may be
present (\3,14). Early diastolic filling (peak filling rate) has
been reported to be depressed in patients with aortic stenosis
(\ 5,16). However, early left ventricular filling is determined
by a complex interplay between the static and dynamic
properties of the left atrium and ventricle. Thus, early filling
is not uniform from patient to patient but varies according to
the degree of hypertrophy, systolic function and left atrial
driving pressures (17).
Relating abnormal diastolic function to symptoms. Abnor-
malities of diastolic function play an important role in almost
all diseases of the heart (7,18,19). However, there has not
been extensive experience in the evaluation of diastolic
dysfunction in clinical situations for several reasons: I)
Diastole is a series of complex, interrelated events and
measurement of these events is difficult. High fidelity pres-
sure measurements and pressure-volume or stress-strain
relations are currently used to provide indexes of these
diastolic events, but there remain many limitations to even
these invasive, time-consuming procedures (20). 2) There is
such a diverse spectrum of diastolic abnormalities in anyone
disease state that a large number of patients must be studied
to establish any reasonable conclusion about the overall
contribution of diastolic abnormalities to pathophysiology.
3) Finally, all measures of diastolic variables are highly
dependent on many factors other than intrinsic myocardial
disease, such as loading conditions, heart rhythm and rate,
and age (8,18,19). Because of these factors, it has been
difficult to directly relate abnormalities of diastolic function
with symptoms or prognosis in various diseases.
The present study. In this issue of the Journal, Sheikh et
al. (21) were able to demonstrate a relation between abnor-
malities of diastolic function and symptoms. The follow-up
of patients after an intervention (such as percutaneous aortic
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balloon valvuloplasty) in a disease with a large component of
diastolic function abnormality (such as aortic stenosis with
left ventricular hypertrophy) is an ideal situation for evalu-
ating these relations because each patient serves as his or her
own control. The finding that diastolic function worsens
immediately after balloon valvuloplasty with prolongation of
relaxation has been supported by others (22,23) and proba-
bly reflects transient myocardial ischemia, which is pro-
duced during balloon inflation (24). At short-term follow-up
patients who remained asymptomatic had improved myocar-
dial relaxation and chamber stiffness, as opposed to those
who developed recurrent symptoms. This sustained symp-
tomatic improvement was not related to more conventional
measurements used clinically in the evaluation of aortic
stenosis, such as ejection fraction, aortic valve gradient or
aortic valve area.
Many questions still need to be answered concerning
these data. All relations were based on symptomatic status,
which is a subjective end point. Because of the critically ill
nature of the patients who underwent valvuloplasty, only
53% of the total group had follow-up studies, so a bias may
be present in the results. There was no correction for body
surface area in any measured variable except for left ven-
tricular mass. Thus, major questions remain as to which
underlying pathophysiologic mechanisms caused these
changes in diastolic variables and why some patients im-
proved when others did not. Although regression of left
ventricular hypertrophy has been proposed, other mecha-
nisms such as changes in afterload or increased coronary
flow reserve may have contributed to improvement in dias-
tolic variables in patients with symptomatic improvement.
Other factors, such as changes in preload, myocardial ische-
mia, coexistent valvular regurgitation or contrast load, could
also affect these diastolic variables. The changes in peak
filling rates are not fully explained because the symptomatic
patients in this study were those with the lower peak filling
rates. This is in discordance with the findings of others
(17,25) who showed that it is patients with the most severe
hypertrophy and higher filling pressures who have higher
rates of peak filling in early diastole.
Clinical implications. Despite these limitations, these
findings have raised important questions not only about the
mechanism of percutaneous aortic balloon valvuloplasty,
but also about the underlying pathophysiologic processes
that contribute to symptoms in patients with aortic stenosis.
They support the hypothesis that abnormalities of diastolic
performance may be an important and perhaps the primary
cause of symptoms in patients with aortic stenosis. Although
diastolic performance has been implicated in the past, un-
derstanding of its influence was based mainly on extrapola-
tion from intricate analyses of a small number of patients at
one point in time. As a greater understanding of the diastolic
filling process develops, it is hoped that more noninvasive
approaches can be used to measure abnormalities of dias-
tolic filling. This should allow evaluation of large numbers of
patients with different disease states in serial fashion to
further define the role of diastolic function in heart disease.
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